SLC31A1 and breast cancer: Interestingly, our study further found that high SLC31A1 expression was resistant to chemotherapy and Trastuzumab, which suggests that SLC31A1 provides a therapeutic marker for addressing chemotherapy and targeted drug resistance in BC.The reason behind it deserves further study.